Skip to content

Clinical trials

Phase 3 Pulmonary Emphysema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Emphysema Phase: Phase 3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20121
20131
20142
20161
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grifols Therapeutics LLC5
Aeris Therapeutics1
Asan Medical Center1
Royal Brompton & Harefield NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Emphysema8
alpha 1-Antitrypsin Deficiency5
Pulmonary Disease, Chronic Obstructive4
Emphysema3
Respiratory Tract Diseases3
Lung Diseases2
Lung Diseases, Obstructive2
Bronchitis, Chronic1
Genetic Diseases, Inborn1
Pathologic Processes1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.